Inquiries by Email
WhatsApp Reservation
Anti-aging stem cell therapy delivers 100–200 million autologous adipose-derived mesenchymal stem cells via IV to target the four cellular drivers of biological aging.
Below: how MSCs target the four hallmarks of aging, what the 2026 RCT (N=148) confirmed, and why Japan’s MHLW-regulated Back-Aging differs from Mexico-style stem-cell tourism.
Cell Grand Clinic in Osaka, Japan grows cells from your own minimal fat tissue over 7 weeks — up to 200 million autologous stem cells via IV, never donor cells.
MHLW Type 2 certified · NIH-trained physician · 3,000+ cases · proprietary Anti-Aging protocol.
- Anti-Aging Stem Cell Therapy: Why Creams, Supplements, and Hormone Therapy Can’t Reverse Biological Aging
- Why Your Body Ages: The 4 Hallmarks Driving Aging
- Can Stem Cells Reverse Aging?
- Does Stem Cell Therapy Actually Work? Evidence on Reversing Aging, Frailty & Longevity
- Why Japan? Why Cell Grand Clinic? The Safety and Quality Difference
- Treatment Flow of Stem Cell Therapy
- What Are the Benefits of Stem Cell Therapy for Anti-Aging?
- Anti-aging at the cellular level — beyond skincare and supplements.
- Stem Cells vs. NMN, Hormones & Other Anti-Aging Therapy
- Common Questions About Anti-Aging Stem Cell Therapy
- Your Next Step: Plan a Stem Cell Anti-Aging Consultation
- References
Anti-Aging Stem Cell Therapy: Why Creams, Supplements, and Hormone Therapy Can’t Reverse Biological Aging
Anti-aging stem cell treatment is an intravenous regenerative therapy that infuses 100–200 million autologous adipose-derived mesenchymal stem cells to address the cellular drivers of aging — stem cell exhaustion, inflammaging, mitochondrial dysfunction, and senescence — that creams, supplements, NMN, and hormone therapy cannot reach.
After 50, the decline is quiet but relentless. Morning stiffness that lingers. Fatigue that persists no matter how much you sleep. A body that no longer recovers the way it once did. Your mind is sharp, your ambition fierce—but your biology is falling behind.
In medicine, this state is called frailty—and it predicts loss of independence and mortality more reliably than almost any single disease. For decades, the only answer was “anti-aging”: supplements, creams, and wishful thinking.
At Cell Grand Clinic in Osaka, Japan, we reject that philosophy. We don’t slow aging. We aim to reverse it. We call this Back-Aging—powered by up to 200 million of your own stem cells, cultivated under Japan’s strictest government oversight and delivered into your bloodstream to repair decades of systemic damage.
This is not cosmetic enhancement. This is a cellular-level reset of your biological age, your longevity, and your quality of life.
Why Your Body Ages: The 4 Hallmarks Driving Aging
Biological aging is driven by four cellular hallmarks: stem cell exhaustion (depletion of mesenchymal repair cells), inflammaging (chronic low-grade systemic inflammation), mitochondrial dysfunction (declining cellular energy production), and cellular senescence (accumulation of “zombie” cells emitting pro-aging signals). Together they explain why frailty progresses and why traditional anti-aging products fall short.
1. Stem Cell Exhaustion: Your Repair Crews Are Vanishing
Your body contains a natural reserve of mesenchymal stem cells (MSCs)—the master repair cells responsible for maintaining and regenerating tissues. Every day, these cells quietly repair micro-damage to muscles, organs, blood vessels, and your immune system. They are the reason a 25-year-old recovers from injury in days while a 65-year-old takes weeks.
The problem: this reserve is not infinite. By your 60s, you retain only a tiny fraction of the MSCs you had in your 20s. Research confirms this stem cell depletion is directly associated with the progression of aging frailty. Without these cellular repair crews, tissue degradation outpaces regeneration. Muscles weaken. Joints stiffen. Organs lose efficiency. The body begins to fail—not from disease, but from cellular exhaustion.
2. Inflammaging: The Silent Fire Destroying You from Within
Scientists have coined a term for one of the most insidious hallmarks of aging: inflammaging—a state of chronic, low-grade systemic inflammation that accumulates silently over decades. Unlike acute inflammation after an injury (which is protective), inflammaging is a slow-burning fire that never extinguishes.
What does inflammaging do? It destroys muscle fibers, causing sarcopenia (age-related muscle loss). It stiffens blood vessels, increasing cardiovascular risk. It impairs cognitive function, contributing to brain fog and memory decline. It suppresses immunity, leaving you vulnerable to infections and cancer. A landmark review in Nature Reviews Cardiology found that elevated TNF-α, IL-6, and CRP levels are independent predictors of mortality in frail patients.
Traditional anti-inflammatory drugs are a band-aid—treating the symptom while ignoring the cause. Back-Aging takes a fundamentally different approach: extinguish the fire at its source by resetting your immune system’s inflammatory balance using the most powerful biological anti-inflammatory agents known—your own stem cells.
3. Mitochondrial Dysfunction: Your Cellular Batteries Are Dying
Every cell in your body contains hundreds to thousands of mitochondria—microscopic organelles often called “the powerhouses of the cell.” These tiny structures convert nutrients into ATP, the molecular fuel powering every biological process: thinking, moving, healing.
As you age, mitochondria accumulate damage and their efficiency plummets. The Journal of Biomedical Science identifies mitochondrial dysfunction as a hallmark of aging, directly linked to the persistent fatigue patients over 50 experience. Your cells simply cannot produce enough energy to maintain peak performance. This is why you feel tired even when you sleep well, eat well, and exercise. The problem is not external—it is inside every cell.
4. Cellular Senescence: Zombie Cells Poisoning Your Body
Senescent cells have stopped dividing but refuse to die. Instead, they linger in your tissues, releasing a toxic cocktail of inflammatory signals known as the SASP (senescence-associated secretory phenotype). These “zombie cells” actively accelerate aging in neighboring healthy cells—spreading biological decay like a contagion.
The accumulation of senescent cells is linked to virtually every age-related disease, from Alzheimer’s to atherosclerosis. A groundbreaking 2025 study in Cell demonstrated that genetically fortified mesenchymal progenitor cells reduced senescence markers systemically in aged primates, enhancing brain architecture, cognition, bone strength, and reproductive health.
Can Stem Cells Reverse Aging?
Stem cell therapy works for anti-aging through three simultaneous mechanisms: (1) systemic homing — infused mesenchymal stem cells migrate to inflamed or aging tissues; (2) mitochondrial transfer — donating healthy mitochondria via tunneling nanotubes and exosomes; and (3) immunomodulation — releasing cytokines that lower TNF-α, IL-6, and CRP throughout the body
Mechanism 1: Systemic Homing — Intelligent Cell Delivery
Stem cells are remarkably intelligent. Once infused into your bloodstream, they detect chemical signals (cytokines, chemokines, growth factors) released by damaged, inflamed, or aging tissues—a process called “homing.” They migrate to where your body needs them most: weakening muscles, stiffening arteries, an overburdened liver, inflamed joints, or a declining brain.
This is fundamentally different from taking a pill or receiving an injection into a single joint. IV stem cell therapy is a whole-body intervention. The cells distribute systemically, repairing damage across multiple organ systems simultaneously.
Mechanism 2: Mitochondrial Transfer — Recharging Your Batteries
One of the most extraordinary discoveries in regenerative medicine: stem cells can physically donate their healthy mitochondria to your aging cells. This occurs through microscopic tunneling nanotubes (TNTs) and extracellular vesicles—tiny bridges that shuttle fresh mitochondria directly into your energy-depleted cells.
The result: restored ATP production, reduced oxidative stress, enhanced cellular resilience. Research in the Journal of Biomedical Science and Signal Transduction and Targeted Therapy confirms this mitochondrial transfer effectively “recharges” cellular energy. Think of it as replacing degraded smartphone batteries with brand-new ones. The hardware is the same—but everything runs faster, lasts longer, and performs better.
Mechanism 3: Anti-Inflammatory Reset + Paracrine Signaling
Stem cells are among the most potent biological anti-inflammatory agents known to science. Once deployed, they release a cascade of immunomodulatory cytokines suppressing inflammaging. Clinical trials demonstrate significant reductions in TNF-α, IL-6, IL-17, and CRP following MSC therapy. Muscles stop breaking down and begin rebuilding. Blood vessels regain flexibility. Brain fog lifts. Joint pain diminishes.
Beyond direct action, infused cells release the secretome—a complex mixture of growth factors, cytokines, and exosomes that orchestrate tissue repair far beyond the cells’ immediate location. These signaling molecules stimulate your body’s own dormant stem cells to reactivate, promote new blood vessel growth (angiogenesis), and encourage tissue regeneration. The infused cells don’t merely repair—they teach your body how to repair itself again.
Reach us directly — WhatsApp and email inquiries are free of charge.
Does Stem Cell Therapy Actually Work? Evidence on Reversing Aging, Frailty & Longevity
Yes — multiple Phase I, Phase II, and Phase IIb randomized controlled trials show that intravenous mesenchymal stem cell therapy improves physical function and lowers inflammatory markers in aging adults. The largest trial to date (Ruiz et al., 2026, N=148) reported a clinically meaningful +63.4-meter improvement on the 6-minute walk test at the 100–200 million cell dose.
The efficacy of anti-aging stem cell (all source) therapy is supported by multiple randomized controlled trials (RCTs)—the gold standard of clinical evidence.
Stem Cell Therapy for Aging Frailty — Key Studies
Multiple randomized controlled trials (RCTs) confirm safety and efficacy at the 100–200 million cell dose range.
| Study | Phase | Key Outcome | Safety |
|---|---|---|---|
| CRATUS Phase I (Golpanian et al.) |
Phase I | 100M dose: 6MWT improvement; reduced TNF-α | Well-tolerated; no SAEs |
| CRATUS Phase II (Tompkins et al.) |
Phase II RCT | Significant improvement in 6MWT, QOL; TNF-α reduction | Well-tolerated; no SAEs |
| Zhu et al. (2024) | Phase I/II RCT | Improved frailty scores, physical function, inflammatory markers | Safe; no tumor formation |
| Sanz-Ros et al. (2022) | Preclinical | Decreased epigenetic age; prevented frailty; improved healthspan | N/A (animal model) |
| Lei et al. (2025) | Preclinical (Primates) | Reversed biological aging clocks; reduced senescence | No serious adverse events |
| Ruiz et al. (2026) | Phase IIb RCT (N=148) |
+63.4 m 6MWT at 9 months (p=0.0077); dose-dependent response confirmed | Well-tolerated; no SAEs |
Why Japan? Why Cell Grand Clinic? The Safety and Quality Difference
Regulatory Framework
Japan’s 2014 Act on the Safety of Regenerative Medicine is among the first comprehensive national legal frameworks specifically governing stem cell treatments. Every clinic must:
- File treatment plans under the framework
- Process cells in licensed pharmaceutical-grade facilities
- Report adverse events to a national database
- Have plans reviewed by an MHLW-certified independent Special Committee
Violations carry criminal penalties under Japanese law. This is a notification and committee-review framework — distinct from US-FDA-style efficacy approval — but provides documented government oversight. Regulatory environments differ across jurisdictions; readers comparing internationally should consider local frameworks.
Cell Grand Clinic: 13 Type II Provision Plans
Cell Grand Clinic holds 13 specifically approved treatment plans (Type 2 and type 3) under MHLW supervision. Type II is the higher-tier risk classification within the Act, applicable to treatments using cultured autologous cells. Every protocol is reviewed by an independent MHLW-Certified Special Committee.
Ultra-Potent Stem Cells (Grand Stem Cells)
Four quality pillars determine the therapeutic effectiveness of stem cell therapy:
Freshness: Cell viability ≥95% at the time of administration, compared to the industry average of 70–85%.
Purity: ≈99% stem cell surface antigen expression verified by CD73+, CD90+, CD105+ markers per ISCT standards, with contaminants CD45− and CD34− eliminated.
Youth: Passage 3 cultivation to maintain maximum differentiation ability; over-passaged cells at P5+ lose regenerative potency.
Guaranteed Dose: 100–200 million cells per administration — the dose range validated by randomized controlled trials for systemic anti-aging effects.
In addition, Grand Stem Cells are never stockpiled or pre-made. Culture begins only after your treatment is confirmed.
Academic Partnership and Expert Oversight
Our cell culture protocols are developed in collaboration with Professor Takahiro Ochiya’s research team, whose work on exosomes and stem cell biology has appeared in top-tier journals. Every treatment plan is personally overseen by Dr. Yuichi Wakabayashi, Diplomate of the American Board of Regenerative Medicine, ensuring care that meets the highest international standards
Treatment Flow of Stem Cell Therapy
Visit 1: Consultation & Harvest (Day 1)
Comprehensive medical assessment including blood work and biomarkers. Dr. Wakabayashi performs a 30-minute tiny fat harvest under local anesthesia. Recovery is immediate—enjoy Osaka’s Michelin-starred dining that same evening.
Optional: You can receive same-day add-on treatments such as an exosome IV infusion, exosome facial treatments, or an NMN IV drip.
Culture Period: 7 Weeks of Precision Science
Return home while your cells are expanded to 100–200 million at cell culture protocols. Rigorous testing: viability, sterility, mycoplasma, endotoxin, and karyotype analysis.
Visit 2: The Infusion
Return to Osaka. Your stem cells are administered via relaxing IV drip over 60–90 minutes. Read, work on your laptop, or rest. Entirely non-surgical.
What Are the Benefits of Stem Cell Therapy for Anti-Aging?
While individual results vary, patients consistently report improvements in three stages:
Weeks 2–4: Neurological Restoration
Deeper, more restorative sleep. Reduced anxiety. Improved mental clarity. These reflect MSCs’ anti-inflammatory effect on the nervous system.
Months 1–3: Physical Vitality
Improved stamina and endurance. Enhanced libido. Reduced joint pain. Greater muscle strength. Many patients return to exercise routines abandoned years ago—not from obligation, but genuine energy.
Months 3–12: Visible Rejuvenation
Improved skin tone and elasticity. Enhanced hair quality. Greater muscle definition. Improved complexion. These external changes confirm deep biological renewal happening within.
Patient insight: Most describe the effect not as “looking younger” but as “feeling like myself again.” This restoration of vitality, confidence, and capability is the true promise of Back-Aging.
Anti-aging at the cellular level — beyond skincare and supplements.
Stem cell therapy — from $19,800 USD per session
$19,800 USD includes:
- 100 million autologous ADSCs
- 7-week culture at MHLW-certified CPC · passage ≤3
- Quality certificate · 95%+ viability
- 1 / 3 / 6 month remote follow-up
Final pricing depends on your individual case:
- Higher cell counts (200 million+)
- Combination protocols
- Multiple sessions
Have Dr. Wakabayashi review your case.
Share your medical history and current treatments. Dr. Wakabayashi reviews each international inquiry and responds with a written feasibility note, recommended protocol, and quote. Typical turnaround: 1–3 business days.
Stem Cells vs. NMN, Hormones & Other Anti-Aging Therapy
Stem cell Back-Aging is the only anti-aging modality that targets all major aging mechanisms — systemic tissue repair, immunomodulation, and mitochondrial energy transfer — across the entire body, with effects lasting 1–3+ years per treatment. By contrast, NMN/NAD+ supplements address cellular energy only and require daily dosing; hormone therapy alleviates hormonal symptoms but effects stop when discontinued; PRP/growth factors work on localized areas for approximately 3 months; and cosmetic surgery alters appearance without addressing underlying biological aging. Only high-dose intravenous stem cell therapy (100–200 million autologous cells) provides whole-body regeneration at the cellular level — repairing tissue, resetting immune function, and recharging mitochondrial energy simultaneously.
Back-Aging vs. Traditional Anti-Aging
Not all anti-aging approaches are equal. Here’s how stem cell Back-Aging compares.
| Modality | Mechanism | Scope | Duration | Effectiveness |
|---|---|---|---|---|
| Stem Cell Back-Aging ★ Gold Standard | Systemic repair, immunomodulation, mitochondrial transfer | Whole Body | 1–3+ Years | |
| NMN / NAD+ Supplements Supplement | Energy molecule precursor | Cellular Energy Only | Daily Dosing Required | |
| Hormone Therapy Hormonal | Hormone supplementation | Hormonal Symptoms | Stops When Discontinued | |
| PRP / Growth Factors Injection | Concentrated growth factors | Localized Only | ~3 Months | |
| Cosmetic Surgery Surgical | Structural alteration | Appearance Only | Temporary |
Common Questions About Anti-Aging Stem Cell Therapy
Q. What is Back-Aging stem cell therapy?
A. Back-Aging is Cell Grand Clinic’s proprietary anti-aging protocol that delivers 100–200 million of your own adipose-derived mesenchymal stem cells via IV infusion to target the four root causes of biological aging: stem cell exhaustion, chronic inflammaging, mitochondrial dysfunction, and cellular senescence. Unlike cosmetic anti-aging treatments that alter appearance, Back-Aging is a cellular-level reset — your stem cells migrate throughout the body, repairing tissue damage, resetting immune function, and recharging cellular energy across multiple organ systems simultaneously.
Q. How many stem cells are used in anti-aging treatment, and why does the dose matter?
A. Cell Grand Clinic delivers 100 to 200 million autologous mesenchymal stem cells per IV session — the dose range validated by multiple randomized controlled trials for systemic anti-aging effects. The largest RCT to date (2026, N=148) confirmed a clinically significant 63.4-meter improvement in the 6-minute walk test at this dose range. Many clinics offer only a few million cells, which research suggests is insufficient for meaningful systemic anti-aging benefit. Cell count is one of the most critical factors determining therapeutic effectiveness.
Q. How often should I repeat anti-aging stem cell therapy?
A. Most patients choose to repeat treatment once per year or every two years for ongoing maintenance — similar to maintaining a high-performance vehicle. Each session rebuilds the cellular infrastructure supporting longevity. The effects of a single treatment typically unfold over 3–12 months: improved sleep and mental clarity in weeks 2–4, enhanced physical vitality and stamina in months 1–3, and visible rejuvenation of skin, hair, and muscle tone in months 3–12.
Q. Is there a cancer risk with stem cell therapy for anti-aging?
A. Cell Grand Clinic uses mesenchymal stem cells (MSCs), which are fundamentally different from iPS or embryonic stem cells and do not form tumors. A comprehensive 2021 meta-analysis covering 15 years of MSC clinical trials found no evidence of tumor formation. Additional safety measures at Cell Grand Clinic include karyotype analysis (genetic stability testing) of every cell batch and full compliance with Japan’s MHLW regulatory standards, which require mandatory adverse event reporting to a national database.
Q. How does stem cell anti-aging therapy compare to NMN supplements or hormone therapy?
A. Stem cell Back-Aging is the only anti-aging modality that targets all major aging mechanisms simultaneously — systemic tissue repair, immunomodulation, and mitochondrial energy transfer — with effects lasting 1–3+ years per treatment. NMN/NAD+ supplements address cellular energy only and require daily dosing. Hormone therapy alleviates hormonal symptoms but effects stop when discontinued. PRP works on localized areas for approximately 3 months. Only high-dose IV stem cell therapy provides whole-body regeneration at the cellular level.
Q. At what age should I consider stem cell anti-aging therapy?
A. Back-Aging is designed for healthy individuals who feel the effects of aging and want to proactively maintain vitality — not wait for disease to develop. By your 40s–50s, NAD+ levels have dropped by half, stem cell reserves are significantly depleted, and inflammaging accelerates. Many patients begin in their 40s–60s when they notice persistent fatigue, slower recovery, declining energy, and reduced physical performance despite maintaining a healthy lifestyle. Treating aging before it becomes disease is the core philosophy.
Your Next Step: Plan a Stem Cell Anti-Aging Consultation
You insure your properties. You hedge your portfolios. You protect your businesses with the best counsel money can buy. But how much have you invested in the one asset that determines whether you can enjoy everything you’ve built?
Your body is your biological capital—and it depreciates every year. At Cell Grand Clinic, we offer what no supplement, hormone pill, or cosmetic procedure can: a chance to biologically reset your cellular machinery. To move beyond the limitations of oral anti-aging treatments. To reverse aging at its source.
Welcome to the future of anti-aging stem cell therapy. Welcome to Back-Aging. It is waiting for you in Osaka.
Reach us directly — WhatsApp and email inquiries are free of charge.
References
[1] Golpanian S et al. Allogeneic human mesenchymal stem cell infusions for aging frailty. J Gerontol A Biol Sci Med Sci. 2017;72(11):1505-1512. https://doi.org/10.1093/gerona/glx056
[2] López-Otín C et al. Hallmarks of aging: An expanding universe. Cell. 2023;186(2):243-278. https://doi.org/10.1016/j.cell.2022.11.001
[3] Yi L et al. The efficacy and safety of β-nicotinamide mononucleotide (NMN) supplementation in healthy middle-aged adults: a randomized, multicenter, double-blind, placebo-controlled, parallel-group, dose-dependent clinical trial. GeroScience. 2023;45(1):29-43. https://doi.org/10.1007/s11357-022-00705-1
[4] Paliwal S et al. Regenerative abilities of mesenchymal stem cells through mitochondrial transfer. J Biomed Sci. 2018;25(1):31. https://doi.org/10.1186/s12929-018-0429-1
[5] Liu D et al. Intercellular mitochondrial transfer as a means of tissue revitalization. Signal Transduct Target Ther. 2021;6(1):65. https://doi.org/10.1038/s41392-020-00440-z
[6] Tompkins BA et al. Allogeneic mesenchymal stem cells ameliorate aging frailty: A phase II randomized, double-blind, placebo-controlled clinical trial. J Gerontol A. 2017;72(11):1513-1522. https://doi.org/10.1093/gerona/glx137
[7] Ferrucci L, Fabbri E. Inflammageing: chronic inflammation in ageing, cardiovascular disease, and frailty. Nat Rev Cardiol. 2018;15(9):505-522. https://doi.org/10.1038/s41569-018-0064-2
[8] Lei J et al. Senescence-resistant human mesenchymal progenitor cells counter aging in primates. Cell. 2025;188(18):5039-5061.e35. https://doi.org/10.1016/j.cell.2025.05.021
[9] Zhu Y et al. Safety and efficacy of umbilical cord-derived MSCs in aging frailty: a phase I/II RCT. Stem Cell Res Ther. 2024;15(1):122. https://doi.org/10.1186/s13287-024-03707-2
[10] Sanz-Ros J et al. Small extracellular vesicles from young adipose-derived stem cells prevent frailty, improve health span, and decrease epigenetic age in old mice. Sci Adv. 2022;8(42):eabq2226. https://doi.org/10.1126/sciadv.abq2226
[11] El-Badawy A et al. Adipose stem cells display higher regenerative capacities and more adaptable electro-kinetic properties compared to bone marrow-derived mesenchymal stromal cells. Sci Rep. 2016;6:37801. https://doi.org/10.1038/srep37801
[12] Wang Y et al. The safety of MSC therapy over the past 15 years: a meta-analysis. Stem Cell Res Ther. 2021;12(1):545. https://doi.org/10.1186/s13287-021-02609-x
[13] Garay RP. Recent clinical trials with stem cells to slow or reverse normal aging processes. Front Aging. 2023;4:1148926. https://doi.org/10.3389/fragi.2023.1148926
[14] Ruiz JG et al. Randomized phase 2b dose-escalation trial of stem cell therapy with laromestrocel for aging frailty. Cell Stem Cell. 2026;33(3). https://doi.org/10.1016/j.stem.2026.01.017
Updated: 2026.05.16
【Author information】
Yuichi Wakabayashi, M.D., Ph.D.
Medical Director, Cell Grand Clinic
Diplomate, American Board of Regenerative Medicine (ABRM)
【About the Author】
Dr. Yuichi Wakabayashi is a regenerative medicine specialist with over 3,000 stem cell treatments performed. After earning his M.D. and Ph.D. at Kobe University, he conducted research at the U.S. National Institutes of Health (NIH) in the field of neurological disorders. His international achievements include first-author publication of the world's first-in-human PDE4B-specific PET tracer study, conducted in collaboration with Pfizer Inc. As Medical Director of Cell Grand Clinic, he combines evidence-based science with rigorous safety standards, dedicated to extending each patient's healthy lifespan through advanced regenerative medicine.
【Specialties】
Regenerative medicine (stem cell therapy) / Anti-aging medicine / Preventive medicine / Aesthetic regenerative medicine
【Board Certifications & Memberships】
Diplomate, American Board of Regenerative Medicine (ABRM) / Board-Certified Specialist, Japan Society of Anti-Aging Medicine / Board-Certified Specialist, Diagnostic Radiology (Japan) / Board-Certified Specialist, Nuclear Medicine (Japan) / Member, Japanese Society for Regenerative Medicine / Member, Japan Society for Dementia Research
【Education & Career】
Kobe University School of Medicine (M.D.) → Kobe University Graduate School (Ph.D.) → Kindai University School of Medicine (Lecturer) → U.S. National Institutes of Health (Research Fellow) → Cell Grand Clinic (Medical Director)
【Publications & Media】
Author: "The Simplest Guide to Regenerative Medicine" (book) / Featured in The Wall Street Journal (U.S.) / Featured on KBS Kyoto Television (Japan) / Multiple publications in international peer-reviewed journals
【Clinical Experience】
Over 3,000 stem cell treatments performed — including osteoarthritis, diabetes, chronic pain, frailty, erectile dysfunction, hair loss, and aesthetic rejuvenation
【Supervisory Statement】
The medical content of this article is supervised by the Medical Director of Cell Grand Clinic — a facility that has filed Type 2 and Type 3 Regenerative Medicine Provision Plans with Japan's Ministry of Health, Labour and Welfare (MHLW) under the Act on the Safety of Regenerative Medicine (Plan No.: PB5240089 and others), following review by an MHLW-Certified Special Committee for Regenerative Medicine. We are committed to providing accurate, evidence-based health information.